13F-HR/A filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR/A for the quarter ended 2020-09-30, filed 2020-11-17, with 46 holding rows worth $781,397,000.
- Accession
- 0001172661-20-002346
- Filer
- CIK 1792126
- Filed
- 2020-11-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, amendment of type restatement, 46 entries on the cover page, a total value of $781,397,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $781,397,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 3,136,981 | $118,390,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 1,600,000 | $61,712,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 2,047,178 | $61,538,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 1,173,188 | $58,472,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 850,000 | $46,869,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,750,000 | $46,830,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 275,000 | $38,618,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,604,392 | $32,393,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 976,894 | $30,059,000 | thousands by filing date | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 550,000 | $23,848,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 721,454 | $20,309,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,020,812 | $18,844,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,200,000 | $17,796,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 500,000 | $17,450,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 750,000 | $16,238,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 250,000 | $15,280,000 | thousands by filing date | |
| CALLIDITAS THERAPEUTICS AB SPONSERED | 13124Q106 | ADS | 550,000 | $13,200,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 5,500,000 | $12,375,000 | thousands by filing date | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 300,920 | $9,723,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 275,000 | $9,600,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 275,000 | $9,323,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 300,000 | $7,401,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 500,000 | $7,190,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 310,000 | $7,090,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC COM | 903214104 | COM | 2,700,000 | $6,318,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 311,578 | $5,608,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 400,000 | $5,440,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 150,000 | $5,325,000 | thousands by filing date | |
| PANDION THERAPEUTICS INC | 698340106 | COM | 450,000 | $5,157,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 330,000 | $5,006,000 | thousands by filing date | |
| OUTSET MEDICAL INC | 690145107 | COM | 100,000 | $5,000,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 159,622 | $4,825,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 344,438 | $4,516,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 100,000 | $4,259,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 300,000 | $3,777,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 123,465 | $3,732,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 50,000 | $3,451,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 300,000 | $3,300,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 136,715 | $3,097,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP | 698102209 | UNIT 99/99/9999 | 200,000 | $2,400,000 | thousands by filing date | |
| ACUTUS MED INC | 005111109 | COM | 75,000 | $2,235,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T206 | UNIT 99/99/9999 | 200,000 | $2,110,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 200,000 | $2,072,000 | thousands by filing date | |
| FS DEV CORP | 303020101 | COM CL A | 100,000 | $1,120,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISTION CO | G31655114 | UNIT 06/09/2027 | 100,000 | $1,100,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 31,100 | $1,001,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-20-002272 | superseded | 2020-11-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001172661-20-002346 | this filing | 2020-11-17 | acceptance time not in the bulk data set |